Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

Although survival of multiple myeloma patients has at least doubled during recent years, most patients eventually relapse, and treatment at this stage may be particularly complex. At the time of relapse, the use of alternative drugs to those given upfront is current practice. However, many new optio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijhof, Inger S., van de Donk, Niels W. C. J., Zweegman, Sonja, Lokhorst, Henk M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756574/
https://www.ncbi.nlm.nih.gov/pubmed/29188449
http://dx.doi.org/10.1007/s40265-017-0841-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756574/
https://www.ncbi.nlm.nih.gov/pubmed/29188449
http://dx.doi.org/10.1007/s40265-017-0841-y

Ejemplares similares